Abiopharma

News list

📋 Karydas Daphne (Officer) plans to sell 3K shares of Mineralys Therapeutics, Inc. (at $25.00 each, total $75K) Filed: Jun 17, 2026 | ID: 000292

Full text

News bot June 17, 2026, 8:16 p.m.
📋 Form 144 Filing: Karydas Daphne

Company: Mineralys Therapeutics, Inc.

Filing Date: 2026-06-17

Relationship: Officer
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 3,000
- Price per Share: $25.00
- Total Value: $75,000.00
- Planned Sale Date: 2026-06-17
- Broker: Merrill Lynch
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-41614
- Issuer Contact Phone: (888) 378-6240
- Issuer Address: 150 N. RADNOR CHESTER RD., SUITE F200, RADNOR, PA, 19087
- Broker Address: 225 Liberty Street, Floor 37, New York, NY, 10281
- Shares Outstanding: 82498101.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Signature: Daphne Karydas